EXELIXIS, INC.

EXEL 10-Q · Q1 2026
API behind this page

EXEL Q1 2026 request

Playground key active
Request URL /api/financials?ticker=EXEL&year=2026&quarter=1
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q1 2026 Q1 2025 YoY
Revenue 610,812 555,447 +10.0%
Show Product Lines breakouts
CABOMETYX 552,773 510,872 +8.2%
Collaboration [Member] 55,835 42,164 +32.4%
COMETRIQ 2,204 2,411 -8.6%
Discounts and allowances -240,377 -208,428 -15.3%
Gross product revenues 795,354 721,711 +10.2%
License 56,948 42,480 +34.1%
License · Collaborative Arrangement with Ipsen 43,532 33,979 +28.1%
License · Collaborative Arrangement with Takeda 7,653 2,759 +177.4%
Product 554,977 513,283 +8.1%
Service -1,113 -316 -252.2%
Service · Collaborative Arrangement with Ipsen -3,964 -1,273 -211.4%
Service · Collaborative Arrangement with Takeda 2,852 957 +198.0%
Show Business Segments breakouts
Reportable Segment 610,812 555,447 +10.0%
Show Geography breakouts
Europe 39,568 32,706 +21.0%
JP 12,698 5,557 +128.5%
US 558,546 517,184 +8.0%
Show Type Of Arrangement breakouts
Collaborative Arrangement with Ipsen 39,568 32,706 +21.0%
Collaborative Arrangement with Takeda 10,505 3,716 +182.7%
Cost of Revenue 19,953 19,172 +4.1%
Show Business Segments breakouts
Reportable Segment 19,953 19,172 +4.1%
Research & Development 199,916 212,233 -5.8%
Show Type Of Arrangement breakouts
Research Collaborations, In-Licensing Arrangements and Other Business Development Activities 7.9 5.3 +49.1%
Selling, General & Administrative 139,602 137,183 +1.8%
Total Costs & Expenses 359,471 368,588 -2.5%
Operating Income 251,341 186,859 +34.5%
Interest Income Other 16,127 19,076 -15.5%
Show Business Segments breakouts
Reportable Segment 16,127 19,076 -15.5%
Other Non-Operating Income (Expense) 219 -245 +189.4%
Income Loss Attributable To Parent 267,687 205,690 +30.1%
Income Tax Expense (Benefit) 57,220 46,074 +24.2%
Show Business Segments breakouts
Reportable Segment 57,220 46,074 +24.2%
Net Income 210,467 159,616 +31.9%
Show Business Segments breakouts
Reportable Segment 210,467 159,616 +31.9%
Show Equity Components breakouts
Retained Earnings 210,467 159,616 +31.9%
EPS (Basic) 0.81 0.57 +42.1%
EPS (Diluted) 0.79 0.55 +43.6%
Wtd Avg Shares (Basic) 258,329 278,804 -7.3%
Wtd Avg Shares (Diluted) 267,322 288,177 -7.2%
Comprehensive Income 206,576 162,973 +26.8%
Other Comprehensive Income -3,891 3,357 -215.9%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -3,891 3,357 -215.9%

Balance Sheet

Balance Sheet
Metric Q1 2026 Q1 2025 YoY
Current Assets
Cash & Cash Equivalents 226,152 183,752 +23.1%
Marketable Securities (Current) 551,055 847,564 -35.0%
Receivables Net Current 328,947 281,637 +16.8%
Inventory 26,605 24,853 +7.0%
Prepaid Expenses & Other Current Assets 75,878 58,696 +29.3%
Total Current Assets 1,208,637 1,396,502 -13.5%
Non-Current Assets
Marketable Securities (Non-Current) 649,144 619,441 +4.8%
Property, Plant & Equipment 95,524 115,030 -17.0%
Deferred Tax Assets 293,730 419,045 -29.9%
Goodwill 63,684 63,684 0.0%
Total Assets 2,593,593 2,837,247 -8.6%
Other Assets
Operating Lease Right Of Use Asset And Other Non Current Assets 282,874 223,545 +26.5%
Current Liabilities
Accounts Payable 24,154 42,840 -43.6%
Accrued Employee Benefits Current 87,512 89,747 -2.5%
Accrued Clinical Liabilities Current 64,804 57,635 +12.4%
Customer Refund Liability Current 65,892 57,840 +13.9%
Accrued Collaboration Liability Current 28,327 25,489 +11.1%
Other Liabilities Current 100,286 125,551 -20.1%
Total Current Liabilities 370,975 399,102 -7.0%
Deferred Revenue (Current) 1,154 2,874 -59.8%
Non-Current Liabilities
Operating Lease Liabilities 169,541 187,125 -9.4%
Other Non-Current Liabilities 117,329 119,996 -2.2%
Total Liabilities 657,845 706,223 -6.9%
Contract With Customer Liability Noncurrent 5,164 3,086 +67.3%
Stockholders' Equity
Common Stock 254 275 -7.6%
Additional Paid-In Capital 2,151,703 2,292,033 -6.1%
Accumulated Other Comprehensive Income -415 2,010 -120.6%
Retained Earnings -215,794 -163,294 -32.2%
Total Stockholders' Equity 1,935,748 2,131,024 -9.2%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -415 2,010 -120.6%
Additional Paid In Capital 2,151,703 2,292,033 -6.1%
Common Stock 254 275 -7.6%
Retained Earnings -215,794 -163,294 -32.2%
Total Liabilities & Equity 2,593,593 2,837,247 -8.6%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q1 2026 YTD Q1 2025 YoY
Operating Activities
Depreciation & Amortization 6,948 7,345 -5.4%
Stock-Based Compensation 29,050 25,930 +12.0%
Noncash Lease Expense 5,994 6,096 -1.7%
Research And Development Asset Acquired Other Than Through Business Combination Written Off 2,025 — —
Other Non-Cash Items -2,019 -4,786 +57.8%
Change in Accounts Receivable -42,031 -16,119 -160.8%
Change in Inventory -3,389 -71 -4673.2%
Change in Prepaid & Other Assets 58,653 20,320 +188.6%
Increase Decrease In Accrued Liabilities 4,044 4,605 -12.2%
Change in Accounts Payable -17,897 8,501 -310.5%
Net Cash from Operations 251,845 211,437 +19.1%
Investing Activities
Payments To Acquire Marketable Securities -274,161 -186,701 -46.8%
Proceeds From Sale And Maturity Of Marketable Securities 225,125 258,917 -13.1%
Capital Expenditures -1,509 -2,952 +48.9%
Payments To Acquire In Process Research And Development -525 -19,500 +97.3%
Net Cash from Investing -51,070 49,764 -202.6%
Financing Activities
Share Repurchases -430,352 -283,934 -51.6%
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options 7,472 11,627 -35.7%
Tax Withholding for Share Compensation -34,231 -22,516 -52.0%
Net Cash from Financing -457,111 -294,823 -55.0%
Other Cash Flow
Net Change in Cash -256,336 -33,622 -662.4%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 226,152 183,752 +23.1%

Values in thousands USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key